Switch to:
Novogen Ltd (NAS:NVGN)
Research and Development
$0.23 Mil (TTM As of Dec. 2013)

This is the expense the company spent on research and development. Novogen Ltd's research and development for the six months ended in Dec. 2013 was $0.53 Mil. Its research and development for the trailing twelve months (TTM) ended in Dec. 2013 was $0.23 Mil.


Definition

This is the expense the company spent on research and development.

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Novogen Ltd Research & Development for the trailing twelve months (TTM) ended in Dec. 2013 was $0.23 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Novogen Ltd Annual Data

Jun04Jun05Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13
Research & Development 5.887.659.0514.0218.0815.136.634.200.870.23

Novogen Ltd Semi-Annual Data

Jun09Dec09Jun10Dec10Jun11Dec11Jun12Dec12Jun13Dec13
Research & Development 8.623.513.252.211.810.310.560.000.230.53
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK